Prohibited Substances and Methods in Sports 2019

The World Anti-Doping Agency WADA has published the 2019 Prohibited List. The list identifies which substances and methods are prohibited in- and out-of-competition and which substances are prohibited in particular sports.

Changes made to the list of prohibited substances and methods for 2019 are minor. No new prohibited substance groups have been added to the list, but some titles have been changed slightly. New examples have been added in different groups. These include, for instance:
–    S2: hypoxia-inducible factor (HIF) activating agents (daprodustat, vadadustat) and macimorelin as a growth hormone secretagogue
–    S3: tretoquinol as a beta-2 agonist
–    S4: several experimental agents that prevent activin receptor IIB activation with different mechanisms.

In the group S6, Stimulants, two additional analogues of the already listed methylhexaneamine (1,4-dimethylpentylamine and 1,2-dimethylpentylamine) were added as examples. They are available in some nutritional supplements sold on the Internet, for instance. However, none of these have been available as pharmacological substances in the market in Finland. Some examples have been removed from the list as they are not available in commercial products (e.g. some examples in the group S1.1b). Nevertheless, these compounds are still prohibited.

“Changes compared to the previous years were minor and none of them has an impact on athletes’ medication in Finland. It is important that WADA pays extremely close attention to potential new doping agents already during the development phase,” says FINCIS’s Medical Expert Pekka Rauhala.

The Prohibited Substances and Methods in Sports 2019 list will be published electronically in Finnish, Swedish and English on the FINCIS website at the beginning of next year. In addition, the KAMU mobile application is available for Android and iOS devices. The search is based on the pharmaceutical databases of the Pharmaceutical Information Centre and includes only prescription medication and over-the-counter medicines available in Finland.

WADA’s documents:
The 2019 Prohibited List
Summary of Major Modifications and Explanatory Notes
The 2019 Monitoring Program

For more information, please contact:
Susanna Sokka
FINCIS – Information Manager
+358 40 740 7477